Market News & Analysis
Week Ahead: Have We Seen the Top in Coronavirus Cases?
Joe Perry February 8, 2020 6:32 AM
Next week will be a pivotal week in terms of discovering if the rate of increase has topped on the number of newly discovered Coronavirus cases. China’s National Health Commission said that as of Thursday, the total infection number was 31,161 and the total number of deaths was 636. However, the Global Times has been reporting that the rate of increase in infection has slowed, as most current cases have already been tested. That means we could see a lowering of new cases moving forward. In addition, they reported that the death rate of coronavirus infections nationwide is 2%, with cities in Hubei, except for Wuhan, declined to 1.3%. In Wuhan, death rate is near 4.1%. There have been unsubstantiated news stories that vaccines may soon be available. Unsubstantiated or not, markets chose to believe it, and add risk in stocks. However, commodities such as oil and copper, and commodity currencies such as the Aussie and Kiwi, are still trading need their 2020 lows. Many companies will reopen on Monday (although many people still encouraged to work from home), and hopes are that this will stem Q1 GDP losses. Today, S&P revised down their annual growth forecast for China to 5.0% from 5.7%.
With the debacle in Iowa this past week in the Democratic caucuses, long shot Pete Buttigieg pulled out the top spot with 13 delegates. Bernie Sanders, Elizabeth Warren, and Joe Biden followed, each receiving 12, 8, and 6 delegates respectively. This was considered a big loss for former Vice President Joe Biden; however, the race has just begun and there’s a long way to go. This week, voters will go to the polls in New Hampshire for the first primary of election season. Buttigieg and Sanders will look to continue the momentum while Biden tries to jump back into the race. (Michael Bloomberg is also running for the democratic nomination; however, he has not been a factor yet).
Beginning of month data came in better than expected, for the most part. Global PMIs were revised higher and US and Canadian payroll data was also better than expected. The only downfall was Industrial Production today out of some European economies (Germany in particular). The second week of the month typically sees a slowdown in data releases. Expected economic highlights are as follows:
- China Inflation Rate
- China PPI
- Canadian Housing Starts and Building Permits
- UK GDP Q4
- UK Trade Balance
- Australian Consumer Confidence
- RBNZ Interest Rate Decision
- Eurozone Industrial Production
- Fed Chair Powell Testimony
- Crude Oil Inventories
- RBA Gov Lane Speech
- BOC Gov Poloz Speech
- Fed Chair Powell Testimony
- Germany GDP Q4
- Eurozone Q4
- US Retail Sales
- US Industrial Production
- US Michigan Consumer Expectations
Chart to Watch: Daily Copper
Source: Tradingview, City Index
Earlier this week, we discussed how copper was down an unprecedented 13 days in a row before bouncing with risk. After testing stops below 2.50, copper bounced into horizontal resistance, however failed from taking out the 38.2% retracement from the highs of January 16th (which was one day after the US-China Phase One trade deal was signed) to the February 3rd lows. In doing so, the base metal formed a shooting star candle, which is a one candlestick reversal formation. This also allowed for the RSI to unwind and move back into neutral territory. However, price today put in a long black bearish candle from 2.598 down to 2.544. If copper trades below 2.480, it has room to run!
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.